BIVI

BioVie Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 8/01/2017
Contact Info
  • 100 Cummings Center
  • Suite 247-C
  • Beverly, MA 01915

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-K
CIK 0001580149
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 2013
Employees Not Available
Company Officers/Contacts
Jonathan Adams CEO, CFO
Amrit Shahzah President, Corporate Secretary
Company Directors
Jonathan Adams Chairman
Cuong Do
James Lang
Amrit Shahzah
Company Notes
  • Formerly=NanoAntibiotics, Inc. until 8-2016
Service Providers
Accounting/Auditing Firm
South Loop CPA
1006 S Michigan Ave
Suite 202
Chicago, IL, 60605
United States

Legal Counsel
Brown, Gee & Wenger LLP
200 Pringle Ave, Suite 400
Walnut Creek, CA, 94596
United States

Investor Relations Firm
Not Available
BIVI Security Details
Share Structure
Market Value1 $18,870,455 a/o Sep 22, 2017
Authorized Shares 300,000,000 a/o Aug 31, 2017
Outstanding Shares 94,352,273 a/o Aug 31, 2017
-Restricted 70,486,790 a/o Aug 31, 2017
-Unrestricted 23,865,483 a/o Aug 31, 2017
Held at DTC 23,865,483 a/o Aug 31, 2017
Float Not Available
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
West Coast Stock Transfer Inc.
Shareholders
Shareholders of Record 97 a/o Aug 24, 2017
Short Selling Data
Short Interest 700 (-22.22%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security